154 related articles for article (PubMed ID: 4585750)
1. [Comparison between alprenolol in tablet form (Aptin) and in "sustained release" form (Aptin Durules) in angina pectoris].
Lorentzen F; Jorgensen P; Nielsen E; Nyberg G; Hvidt S
Ugeskr Laeger; 1973 Jul; 135(27):1431-8. PubMed ID: 4585750
[No Abstract] [Full Text] [Related]
2. Alprenolol in angina pectoris. A comparative study of the tablet form and slow-release formulation.
Lorentzen F; Jorgensen P; Nielsen E; Nyberg G; Hvidt S
Med J Aust; 1975 Oct; 2(17):668-73. PubMed ID: 1107769
[TBL] [Abstract][Full Text] [Related]
3. Slow-release metoprolol in angina pectoris. A comparative study of a cardioselective beta-blocking drug, metoprolol, in ordinary and slow-release tablets (Durules) in the treatment of angina pectoris.
Uusitalo AJ; Keyriläinen O
Ann Clin Res; 1979 Oct; 11(5):199-204. PubMed ID: 44671
[TBL] [Abstract][Full Text] [Related]
4. Prindolol (Visken) and alprenolol (Aptin) in angina pectoris: a comparative clinical study with special reference to ergometer working capacity tests.
Bjerle P; Jacobsson KA
Curr Ther Res Clin Exp; 1974 Feb; 16(2):101-16. PubMed ID: 4218804
[No Abstract] [Full Text] [Related]
5. Effects of alprenolol on central hemodynamics and exercise tolerance in patients with angina pectoris.
Jonsson B; Olsson AG; Orö L
Cardiology; 1973; 58(3):152-61. PubMed ID: 4149331
[No Abstract] [Full Text] [Related]
6. Comparison of two adrenergic beta-receptor blocking agents, alprenolol and propranolol, in treatment of angina pectoris.
Heterington DJ; Comerford MB; Nyberg G; Besterman EM
Br Heart J; 1973 Mar; 35(3):320-33. PubMed ID: 4632566
[No Abstract] [Full Text] [Related]
7. Alprenolol alone and in conjunction with pentanitrol in angina pectoris. A double-blind study with exercise tests.
Hansen PF; Rasmussen PA; Nyberg G
Acta Med Scand; 1973 May; 193(5):419-24. PubMed ID: 4197873
[No Abstract] [Full Text] [Related]
8. [Evaluation of aptine, a new adrenergic beta blockader, in angina pectoris].
Leduc G; Guiha N
Union Med Can; 1971 May; 100(5):969-72. PubMed ID: 4147301
[No Abstract] [Full Text] [Related]
9. Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
Arstila M; Iisalo E; Kallio V
Ann Clin Res; 1969 May; 1(1):13-21. PubMed ID: 4390794
[No Abstract] [Full Text] [Related]
10. Pindolol and alprenolol in angina pectoris: a comparative clinical study.
Frithz G; Nordgren L
Curr Ther Res Clin Exp; 1975 Feb; 17(2):133-8. PubMed ID: 803426
[No Abstract] [Full Text] [Related]
11. Treatment of angina pectoris with metoprolol. A comparison between Durules administered once daily and tablets administered twice daily.
Orö L
Ann Clin Res; 1981; 13 Suppl 30():58-60. PubMed ID: 6794419
[TBL] [Abstract][Full Text] [Related]
12. -Receptor antagonists in angina pectoris.
Prichard BN
Ann Clin Res; 1971 Dec; 3(6):344-52. PubMed ID: 4400460
[No Abstract] [Full Text] [Related]
13. [Effect of sustained release alprenolol in hypertension uncontrolled by chlorothiazide and dihydralazine. Study in double blind (author's transl)].
Cartier F; Merot ML
Sem Hop; 1978 Sep 18-25; 54(25-28):855-7. PubMed ID: 214866
[TBL] [Abstract][Full Text] [Related]
14. Effects of cedilanid-D and alprenolol in angina pectoris.
Ekelund LG; Johnsson G; Melcher A; Orö L
Eur J Clin Pharmacol; 1973 Aug; 6(2):113-8. PubMed ID: 4769694
[No Abstract] [Full Text] [Related]
15. The effect of alprenolol on hemodynamics in angina pectoris.
Cullhed I
Acta Med Scand; 1973 May; 193(5):411-8. PubMed ID: 4717322
[No Abstract] [Full Text] [Related]
16. [Evaluation of the efficacy of verapamil in a slow-release preparation in the treatment of stable exertion angina].
Scrutinio D; Lagioia R; De Toma L; Mangini S; Accettura D; De Nicolò M; Antuofermo F; Rizzon P
Cardiologia; 1982 Oct; 27(10):963-71. PubMed ID: 6765260
[No Abstract] [Full Text] [Related]
17. Alprenolol ("aptin") in angina pectoris. A double-blind multicentre trial.
Hickie JB
Med J Aust; 1970 Aug; 2(6):268-72. PubMed ID: 4393977
[No Abstract] [Full Text] [Related]
18. Comparative study of alprenolol and methyldopa in previously untreated essential hypertension.
Vedin JA; Wilhelmsson CE; Werkö L
Br Heart J; 1973 Dec; 35(12):1285-92. PubMed ID: 4586374
[No Abstract] [Full Text] [Related]
19. The effect of alprenolol in combination with hydralazine in essential hypertension. A double-blind, crossover study and a long-term follow-up study.
Pape J
Acta Med Scand Suppl; 1974; 554():55-62. PubMed ID: 4593674
[No Abstract] [Full Text] [Related]
20. Metoprolol in angina pectoris complicated by essential hypertension. A clinical comparison of the antianginal efficacy of metoprolol slow-release tablets (Durules) given once daily and propranolol tablets given twice daily.
BLoem TJ; Lindner PC
Ann Clin Res; 1981; 13 Suppl 30():61-7. PubMed ID: 6794420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
